How would you like to get rid of unsightly body fat, maintain a trim figure and address symptoms that cause diabetes – without having to go on a radical, demanding diet or suffer the side-effects of drugs?
Celergen, the world’s only Swiss Marine oral cell therapy supplement, is proven to prevent unhealthy body fat accumulation, which aids in maintaining a healthy body weight and reduces the risk of obesity, whilst alleviating symptoms of type II diabetes.
That’s because one of Celergen’s ingredients is a marine protein hydrolysate known as Peptide N, proven to reduce dietary glycemic index or GI. Foods with high GI cause high and prolonged peaks of blood glucose and insulin levels, while foods with relatively low GI cause smaller peaks and fluctuations in blood glucose and insulin levels.
Glucose that enters blood from food is used for energy production in the body’s cells, while excess glucose is transformed into fat and stored for later use. Over time this constant storage of fat leads to obesity. Second, frequent sharp, prolonged peaks of blood glucose and insulin (from high GI foods) are known to increase risk for insulin resistance and type II diabetes. On the other hand, a gradual release of blood glucose (from low GI foods) does not affect this risk and also delays hunger pangs. Finally, Peptide N has been shown to reduce appetite and promote satiety via its actions on metabolic hormones.
Decreasing dietary GI via regular Celergen consumption is a safe, natural approach that will help you avoid body fat accumulation – helping you maintain a healthy body weight and alleviate symptoms of type II diabetes and other lifestyle-related diseases in the process.
As Dr. Uzzi Reiss, founder of the Beverly Hills Anti-Aging Center for Men and Women testifies:
“CELERGEN IS A REMARKABLE TOOL THAT CAN HELP IMPROVE OUR WELL BEING ON MULTIPLE LEVELS. IT IS THE ROLLS ROYCE OF SUPPLEMENTS FOR THE HUMAN BODY.“
BLOOD GLUCOSE RESPONSE AFTER 4 MEALS DIFFERING BY THEIR PROTEIN TYPE CONTENT
This figure shows the results of a study evaluating the effects of 4 different proteins – Peptide N, fish fillet, casein milk protein and soy protein isolate – on blood glucose levels in 17 female volunteers (aged 32-64 years). Each volunteer consumed these proteins in random order, always as part of composite meals of similar macronutrient composition with a 1-week gap between each meal.
Blood samples were taken from each volunteer to assess levels of glucose, insulin and other biomarkers in the fasting state and 7 times after each meal, for up to 240 minutes.
This study found that Peptide N supplementation resulted in a significantly blunted blood glucose response than with fish fillet protein or soy protein isolate. In other clinical studies, Peptide N has been shown to reduce appetite and promote satiety via its actions on metabolic hormones.